810132C
18:1-06:0 NBD PC
Manufacturer: Sigma Aldrich
CAS Number: 106974-05-4
Synonym(S): 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810132C-1-MG | In Stock | ₹ 21,345.75 |
810132C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 21,345.75
GST (18%): ₹ 3,842.235
Total Price: ₹ 25,187.985
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810132C-1mg)
manufacturer/tradename
Avanti Polar Lipids 810132C
concentration
1 mg/mL (810132C-1mg)
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 106974-05-4 | 18:1-06:0 NBD PC | A2B Chem | -- |
Related Products
Description
- General description: Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 18:1-06:0 NBD PC is a fluorescent lipid analog/probe.[1][2]
- Application: 18:1-06:0 NBD PC is suitable for use:as a component in preparing lipid solution for bilayer formation[1]to use as a single donor in fluorescence resonance energy transfer (FRET) based assay[2]to prepare phospholipid-coated beads[3]
- Biochem/physiol Actions: NBD‐PC can be used to probe the existence of (Rho‐labeled) protease‐activated receptor (PAR) pepducins in the outer and inner leaflets.[2]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810132C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810132C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810132C
concentration: 1 mg/mL (810132C-1mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810132C-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810132C
concentration:
1 mg/mL (810132C-1mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810141P-1mg)pkg of 5 × 2 mg (810141P-10mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810141P-1mg)pkg of 5 × 2 mg (810141P-10mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810144P-1mg)pkg of 5 × 1 mg (810144P-5mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810144P-1mg)pkg of 5 × 1 mg (810144P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810145C-1mg)pkg of 5 × 1 mL (810145C-5mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: 1 mg/mL (810145C-1mg)1 mg/mL (810145C-5mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810145C-1mg)pkg of 5 × 1 mL (810145C-5mg)
manufacturer/tradename:
Avanti Polar Lipids
concentration:
1 mg/mL (810145C-1mg)1 mg/mL (810145C-5mg)
shipped in:
dry ice
storage temp.:
−20°C